HCW Biologics Inc. (HCWB)
0.31
0.01 (2.58%)
At close: Mar 27, 2025, 3:59 PM
0.30
-1.70%
After-hours: Mar 27, 2025, 07:46 PM EDT
2.58% (1D)
| Bid | 0.28 |
| Market Cap | 13.6M |
| Revenue (ttm) | 4.12M |
| Net Income (ttm) | -43.97M |
| EPS (ttm) | -1.01 |
| PE Ratio (ttm) | -0.3 |
| Forward PE | -0.59 |
| Analyst | n/a |
| Ask | 0.31 |
| Volume | 80,624 |
| Avg. Volume (20D) | 6,324,922 |
| Open | 0.30 |
| Previous Close | 0.30 |
| Day's Range | 0.30 - 0.31 |
| 52-Week Range | 0.21 - 2.52 |
| Beta | 0.71 |
About HCWB
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata ...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 20, 2021
Employees 45
Stock Exchange NASDAQ
Ticker Symbol HCWB
Website https://www.hcwbiologics.com
1 month ago
+128.58%
HCW Biologics shares are trading higher after the ...
Unlock content with
Pro Subscription
4 months ago
+320.91%
HCW Biologics shares are trading higher after the company entered into an exclusive licensing deal with WY Biotech for immunotherapy development.
